Increased RHAMM expression relates to ovarian cancer progression
Abstract Background Elevated hyaluronan-mediated motility receptor (RHAMM) has been reported to contribute to disease progression, aggressive phenotype and poor prognosis in multiple cancer types, however, RHAMM’s role in ovarian cancer (OC) has not been elucidated. Therefore, we sought to evaluate...
Main Authors: | Stephanie T. Buttermore, Mitchel S. Hoffman, Ambuj Kumar, Anne Champeaux, Santo V. Nicosia, Patricia A. Kruk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-017-0360-1 |
Similar Items
-
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients
by: Marie Beck Enemark, et al.
Published: (2022-03-01) -
Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
by: Leticia Oliveira-Ferrer, et al.
Published: (2022-11-01) -
HMMR promotes invasion and metastasis of hepatocellular carcinoma via activating MEK/ERK signaling pathway
by: LI Xun, et al.
Published: (2022-09-01) -
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
by: Gloria Mittica, et al.
Published: (2020-05-01) -
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
by: Minna Sopo, et al.
Published: (2019-06-01)